María Sol Ballari
Lipophilic modification of Salirasib modulate the antiproliferative and antimigratory activity
Ballari, María Sol; Porta, Exequiel O.J.; Arel Zalazar, Evelyn; Borini Etichetti, Carla M.; Padrón, José M.; Girardini, Javier; Labadie, Guillermo R.
Authors
Dr Exequiel Porta exequiel.o.porta@durham.ac.uk
Post Doctoral Research Associate
Evelyn Arel Zalazar
Carla M. Borini Etichetti
José M. Padrón
Javier Girardini
Guillermo R. Labadie
Abstract
Salirasib, or farnesylthiosalicylic acid (FTS), is a salicylic acid derivative with demonstrated antineoplastic activity. While designed as a competitor of the substrate S-farnesyl cysteine on Ras, it is a potent competitive inhibitor of isoprenylcysteine carboxymethyl transferase. In this study, the antiproliferative activity on six different solid tumor cell lines was evaluated with a series of lipophilic thioether modified salirasib analogues, including those with or without a 1,2,3-triazole linker. A combination of bioassay, cheminformatics, docking, and in silico ADME-Tox was also performed. SAR analysis that analogues with three or more isoprene units or a long aliphatic chain exhibited the most potent activity. Furthermore, three compounds display superior antiproliferative activity than salirasib and similar potency compared to control anticancer drugs across all tested solid tumor cell lines. In addition, the behavior of the collection on migration and invasion, a key process in tumor metastasis, was also studied. Three analogues with specific antimigratory activity were identified with differential structural features being interesting starting points on the development of new antimetastatic agents.
Citation
Ballari, M. S., Porta, E. O., Arel Zalazar, E., Borini Etichetti, C. M., Padrón, J. M., Girardini, J., & Labadie, G. R. (2023). Lipophilic modification of Salirasib modulate the antiproliferative and antimigratory activity. Bioorganic and Medicinal Chemistry, 92, Article 117417. https://doi.org/10.1016/j.bmc.2023.117417
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 16, 2023 |
Online Publication Date | Jul 17, 2023 |
Publication Date | Sep 7, 2023 |
Deposit Date | Jun 20, 2023 |
Journal | Bioorganic & Medicinal Chemistry |
Print ISSN | 0968-0896 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 92 |
Article Number | 117417 |
DOI | https://doi.org/10.1016/j.bmc.2023.117417 |
Public URL | https://durham-repository.worktribe.com/output/1172104 |
Related Public URLs | https://chemrxiv.org/engage/chemrxiv/article-details/644801f2e4bbbe4bbf3d6796 |
You might also like
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
(2023)
Journal Article
Mapping the Evolution of Activity-Based Protein Profiling: A Bibliometric Review
(2023)
Journal Article
Discovery of Leishmania Druggable Serine Proteases by Activity-Based Protein Profiling
(2022)
Journal Article